Related Experiment Video

Updated: Feb 17, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.1K

Comparative evaluation of dynamic risk stratification according to ATA 2015 and ATA 2025 in low-risk differentiated

Pablo Fernández Velasco1,2, Paula Peciña Melgosa3, Beatriz Torres Torres4,5

  • 1Centro de Investigación de Endocrinología y Nutrición Clínica (CIENC), Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain. pablo.fernandez.velasco@alumnos.uva.es.

Endocrine
|February 16, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ATA guidelinesAnti-thyroglobulin antibodiesDifferentiated thyroid carcinomaDynamic risk stratificationLow-risk thyroid cancerThyroglobulin

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.4K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.1K

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
539